Evidence map›Paper›PMID 30112033›Full record

ArticleExperimental and therapeutic medicine2018

Matrine inhibits the proliferation and migration of lung cancer cells through regulation of the protein kinase B/glycogen synthase kinase-3β signaling pathways.

Wang Xie, Jingjing Lu, Qingchun Lu, Xian Wang, Haihu Long, Jianhao Huang, Zhongliang Guo

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Research Advances on Matrine.Frontiers in chemistry · 2022
    Review
  5. Effects ofFrontiers in pharmacology · 2022
    Article
  6. Article
  7. Anti-Tumor Activities of Bioactive Phytochemicals inCancer management and research · 2020
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Wang XieDepartment of Respiratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China.
Jingjing LuDepartment of Respiratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China.
Qingchun LuDepartment of Respiratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China.
Xian WangDepartment of Respiratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China.
Haihu LongDepartment of Respiratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China.
Jianhao HuangDepartment of Respiratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China.
Zhongliang GuoDepartment of Respiratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China.
Shanghai East Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is the leading cause of cancer-related mortality worldwide. Despite recent advances in treatment, lung cancer remains an incurable disease. Matrine, an active compound isolated from

Indexed as

apoptosisglycogen synthase kinase-3βinvasionlung cancermatrinemigrationproliferationprotein kinase B

Identifiers

PMID30112033
PMCPMC6090456
OpenAlexW2807550424

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.